Executive Committee

The Multiple Myeloma Research Foundation’s executive committee works to push the industry forward by executing innovative, ground-breaking research initiatives that accelerates the development of treatments for multiple myeloma.

Whether you are a healthcare professional, a patient, or have a loved one that has been diagnosed with multiple myeloma, the MMRF executive committee is dedicated to providing you with exceptional knowledge and broadening general awareness of precision medicine through events and global educational programs.

Meet the MMRF team below.

 


Kathy Giusti, Founder and Chief Mission Officer MMRF and MMRC
Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). She is also the Chief Mission Officer of the MMRF. Kathy is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of the HBS Kraft Precision Medicine Accelerator. Kathy has more than two decades of experience in the pharmaceutical industry, previously holding senior positions at G.D. Searle and Merck.

Learn more about Kathy Giusti

Paul Giusti, President and Chief Executive Officer
Paul Giusti is the President and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF), a world-renown cancer-research organization. Prior to the MMRF, Mr. Giusti worked as a Chief Executive Officer, leader, executive and entrepreneur for over 30 years; he has founded, managed and led a variety of businesses. Early in his career, Mr. Giusti worked as an executive for GE where he held a number of management positions with a wide range of responsibilities.

Learn more about Paul Giusti


Michael Andreini, Chief Operating Officer 

Michael Andreini joined the MMRF as the Chief Operating Officer in 2019, and is responsible for overseeing day-to-day operations, strategic programs, and alliances across the foundation.  Michael brings over 12 years of strategic consulting and operational experience in the life sciences industry.  Prior to joining the MMRF, Michael was an Associate Principal at IQVIA in the consulting services organization where he led complex engagements for biopharma, medical device, and non-profit organizations across diverse solution areas including commercial assessments, portfolio analysis, R&D and launch strategy, and operational execution.

Learn more about Michael Andreini


Daniel Auclair, PhD. Chief Scientific Officer
Dr. Daniel Auclair, who managed the MMRF Multiple Myeloma Genomics Initiative from 2007-2010, has rejoined the company after three years at the Broad Institute of MIT and Harvard.As senior leader in the Cancer Program at the Broad Institute, Dr. Auclair was involved with a wide range of academic and industry collaborations centered around cancer genomics and personalized medicine.

Learn more about Dr. Daniel Auclair


Steven Labkoff, MD, FACP, FACMI, Chief Data Officer
Dr. Steven Labkoff is a global medical leader with a track record of developing cutting edge strategies towards new healthcare delivery models. He has demonstrated success in the convergence of medicine, life sciences and policy across disparate organizations including government, non-government organizations (NGOs), health plans and academic institutions.He currently Chief Data Officer at the Multiple Myeloma Research Foundation.

Learn more about Dr. Steven Labkoff


Rob Miani , Chief Financial Officer
Rob Miani joined the MMRF team as Chief Financial Officer in 2016. Most recently he was the Vice President of Finance and Corporate Controller of Aptuit, LLC, a global contract research organization providing integrated early discovery to mid-phase drug development services in the pharmaceutical industry.

Learn more about Rob Miani


Anne Quinn Young, MPH, Chief Marketing and Development Officer
Anne Quinn Young, MPH, is the Chief Marketing and Development Officer at the MMRF and is responsible for overseeing the strategy and execution of the organization’s marketing, communications, patient engagement, and fundraising efforts in support of the organization’s mission to accelerate precision medicine and a cure for every patient. 

Learn more about Anne Quinn Young


Karen Dietz, Corporate Counsel and Secretary
Karen Dietz joined the MMRF as Corporate Counsel and Secretary in 2007. She oversees corporate governance, contract negotiations, compliance, and manages the intellectual property portfolio for the MMRF and its subsidiary companies. In recent years, Karen has focused her efforts on the contracts and compliance for MMRF’s landmark CoMMpassSM Study, the MMRF Prevention Project, the MMRF Immunotherapy Initiative, and the MMRF Answer Fund.

Learn more about Karen Dietz


Laura Gilman, Vice President of Events
Laura Gilman is the Vice President of Events at the MMRF where she manages the entire events portfolio. Prior to joining the MMRF in 2010 Ms. Gilman was the Vice President of Citigroup’s Investment Research Conferences where she directed the design and execution of the bank’s high profile research conferences and events.

Learn more about Laura Gilman


Steve Varley, Vice President, Development
Steve Varley joined the MMRF team in 2018 and is responsible for the fundraising efforts of the organization. Most recently he served as Associate Dean for Advancement at Yale University, leading the fundraising efforts for Yale School of Nursing.

Learn more about Steve Varley


Christopher Williams, Vice President of Business Development
Christopher Williams was named Vice President of Business Development at the MMRF in 2017 responsible for business development, partnership and joint venture efforts for the foundation. He is a business development leader with a strong scientific background, specializing in the pharmaceutical and diagnostics space.

Learn more about Chris Williams